GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $445,000 | -15.6% | 10,226 | -15.5% | 0.02% | +4.5% |
| Q1 2022 | $527,000 | +5.2% | 12,096 | +6.4% | 0.02% | 0.0% |
| Q4 2021 | $501,000 | +32.2% | 11,368 | +14.7% | 0.02% | +15.8% |
| Q3 2021 | $379,000 | -1.3% | 9,909 | +2.7% | 0.02% | 0.0% |
| Q2 2021 | $384,000 | +24.7% | 9,647 | +11.7% | 0.02% | +5.6% |
| Q1 2021 | $308,000 | -4.3% | 8,634 | -1.1% | 0.02% | -18.2% |
| Q4 2020 | $322,000 | +198.1% | 8,729 | +203.7% | 0.02% | -46.3% |
| Q3 2020 | $108,000 | -62.0% | 2,874 | -58.8% | 0.04% | +64.0% |
| Q2 2020 | $284,000 | -3.1% | 6,968 | -9.8% | 0.02% | -19.4% |
| Q1 2020 | $293,000 | -30.7% | 7,721 | -14.3% | 0.03% | -6.1% |
| Q4 2019 | $423,000 | +48.9% | 9,013 | +35.2% | 0.03% | +13.8% |
| Q3 2019 | $284,000 | +11.8% | 6,665 | +5.4% | 0.03% | 0.0% |
| Q2 2019 | $254,000 | -10.6% | 6,323 | -9.2% | 0.03% | -32.6% |
| Q3 2017 | $284,000 | -21.8% | 6,964 | -18.2% | 0.04% | -25.9% |
| Q2 2017 | $363,000 | -50.3% | 8,512 | -50.9% | 0.06% | -56.1% |
| Q1 2017 | $730,000 | -0.7% | 17,342 | -7.9% | 0.13% | -8.3% |
| Q4 2016 | $735,000 | -5.4% | 18,822 | +4.5% | 0.14% | -7.7% |
| Q3 2016 | $777,000 | +1.0% | 18,008 | +1.5% | 0.16% | -1.9% |
| Q2 2016 | $769,000 | +12.1% | 17,738 | +4.9% | 0.16% | +3.9% |
| Q1 2016 | $686,000 | +61.4% | 16,917 | +60.5% | 0.15% | +64.5% |
| Q4 2015 | $425,000 | -1.4% | 10,537 | -6.0% | 0.09% | -14.7% |
| Q3 2015 | $431,000 | +6.2% | 11,210 | +14.9% | 0.11% | +12.4% |
| Q2 2015 | $406,000 | -9.8% | 9,757 | -1.9% | 0.10% | -3.0% |
| Q1 2015 | $450,000 | +3.7% | 9,943 | -2.1% | 0.10% | -7.4% |
| Q4 2014 | $434,000 | +13.9% | 10,154 | +22.7% | 0.11% | +4.9% |
| Q3 2014 | $381,000 | +34.6% | 8,278 | +56.5% | 0.10% | +33.8% |
| Q2 2014 | $283,000 | +0.4% | 5,288 | +0.0% | 0.08% | -13.5% |
| Q1 2014 | $282,000 | 0.0% | 5,287 | +0.0% | 0.09% | -6.3% |
| Q4 2013 | $282,000 | -1.4% | 5,286 | -6.4% | 0.10% | -12.0% |
| Q3 2013 | $286,000 | -3.1% | 5,647 | -3.9% | 0.11% | -21.2% |
| Q2 2013 | $295,000 | – | 5,878 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |